Enveric Biosciences, Inc. Increase (Decrease) in Accounts Receivable
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2020-11-16
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-09-30 was $268.87K.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-06-30 was -$807.17K.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was $1.72M, a 66.96% increase year-over-year.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2019-12-31 was -$2.16M, a 5168.27% decline year-over-year.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2019 was -$1.49M.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2018 was -$967.03K, a 224.21% decline from fiscal 2017.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2017 was $778.54K, a 75.58% decline from fiscal 2016.
- Enveric Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2016 was $3.19M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | $268.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$538.30K derived: sum of 2 quarters · filed 2020-11-16 | $1.18M 10-Q · filed 2020-11-16 | -$981.35K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2020-06-30 | -$807.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $910.43K 10-Q · filed 2020-08-14 | -$1.25M derived: sum of 3 quarters · filed 2020-08-14 | -$1.25M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2020-03-31 | $1.72M 10-Q · filed 2020-05-15 | -$443.05K derived: sum of 2 quarters · filed 2020-08-12 | -$443.05K derived: sum of 3 quarters · filed 2020-11-16 | -$798.42K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-12-31 | -$2.16M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | -$2.16M derived: sum of 2 quarters · filed 2020-11-16 | -$2.52M derived: sum of 3 quarters · filed 2020-11-16 | -$1.49M 10-K/A · filed 2020-08-12 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$355.36K derived: sum of 2 quarters · filed 2020-11-16 | $673.38K 10-Q · filed 2020-11-16 | -$261.99K 10-Q · filed 2019-11-08 | $716.01K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$355.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $673.38K 10-Q · filed 2020-08-14 | $716.01K derived: sum of 3 quarters · filed 2020-08-14 | $608.23K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $1.03M 10-Q · filed 2020-05-15 | $1.07M derived: sum of 2 quarters · filed 2020-08-12 | $963.59K derived: sum of 3 quarters · filed 2020-08-12 | $442.54K derived: sum of 4 quarters · filed 2020-08-12 | |
| 2018-12-31 | $42.63K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | -$65.15K derived: sum of 2 quarters · filed 2020-08-12 | -$586.21K derived: sum of 3 quarters · filed 2020-08-12 | -$967.03K 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | -$107.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$628.84K derived: sum of 2 quarters · filed 2019-11-08 | -$1.01M 10-Q · filed 2019-11-08 | -$1.34M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | -$521.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$901.88K 10-Q · filed 2019-08-14 | -$1.23M derived: sum of 3 quarters · filed 2019-08-14 | -$783.63K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$380.83K 10-Q · filed 2019-05-14 | -$709.46K derived: sum of 2 quarters · filed 2019-05-14 | -$262.58K derived: sum of 3 quarters · filed 2019-05-14 | -$1.13M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$328.63K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $118.25K derived: sum of 2 quarters · filed 2019-03-26 | -$751.99K derived: sum of 3 quarters · filed 2019-03-26 | $778.54K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $446.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$423.36K derived: sum of 2 quarters · filed 2018-11-14 | $1.11M 10-Q · filed 2018-11-14 | $1.44M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$870.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $660.29K 10-Q · filed 2018-08-14 | $995.34K derived: sum of 3 quarters · filed 2018-08-14 | $4.59M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $1.53M 10-Q · filed 2018-05-15 | $1.87M derived: sum of 2 quarters · filed 2018-05-15 | $5.46M derived: sum of 3 quarters · filed 2018-05-15 | $4.66M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $335.05K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $3.93M derived: sum of 2 quarters · filed 2018-04-02 | $3.13M derived: sum of 3 quarters · filed 2018-04-02 | $3.19M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.80M derived: sum of 2 quarters · filed 2017-11-13 | $2.85M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$795.73K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-14 | -$738.51K 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $57.22K 10-Q/A · filed 2017-05-15 |